非中脑周围型血管造影阴性蛛网膜下腔出血的功能结局与迟发性脑缺血与动脉瘤性蛛网膜下腔出血相似
基于2006年4月至2014年12月前瞻性自发性蛛网膜下腔出血数据库1311例患者的资料,共识别出191例(11%)血管造影阴性患者,其中83例(4.9%)判定为非中脑周围型血管造影阴性蛛网膜下腔出血(NPAN-SAH)。在校正Fisher分级、性别和糖尿病后,NPAN-SAH患者发生血管痉挛的几率更低(OR 0.197,95%CI 0.07-0.55,P=0.002);但两组在再出血、脑积水、癫痫发作和迟发性脑缺血方面无统计学差异,功能结局不良(改良Rankin量表≥3分;OR 1.16,95%CI 0.615-2.20,P=0.6420)和死亡(OR 1.22,95%CI 0.362-4.132,P=0.7455)与动脉瘤性SAH相当。
要点
- NPAN-SAH患者血管痉挛风险可能更低,但迟发性脑缺血、功能结局不良和死亡与动脉瘤性SAH相当。
- NPAN-SAH占自发性SAH的4.9%(83/1311),占血管造影阴性者的83/191。
- 作者认为可能需要进一步研究以进一步阐明这些发现。
核心结论
- 尽管NPAN-SAH患者血管痉挛风险可能更低,但其迟发性脑缺血、功能结局不良和死亡与动脉瘤性SAH患者相当。
- 作者认为可能需要进一步研究以进一步阐明这些发现。
研究设计与样本
- 前瞻性自发性蛛网膜下腔出血数据库,2006年4月至2014年12月期间共纳入1311例患者。
- 纳入所有NPAN-SAH且连续2次脑血管造影阴性的患者。
- 共识别191例(11%)血管造影阴性患者,其中83例(4.9%)判定为NPAN-SAH。
主要发现
- 校正Fisher分级、性别和糖尿病后,NPAN-SAH患者发生血管痉挛的几率更低(OR 0.197,95%CI 0.07-0.55,P=0.002)。
- 另一校正Hunt和Hess临床分级的模型中,NPAN-SAH患者发生血管痉挛的几率也更低(OR 0.2,95%CI 0.07-0.57,P=0.002)。
- 两组在再出血、脑积水、癫痫发作或迟发性脑缺血方面无统计学显著差异。
- NPAN-SAH患者功能结局不良(改良Rankin量表≥3分;OR 1.16,95%CI 0.615-2.20,P=0.6420)与动脉瘤性SAH相当。
- NPAN-SAH患者死亡(OR 1.22,95%CI 0.362-4.132,P=0.7455)与动脉瘤性SAH相当。
局限性
- 作者认为可能需要进一步研究以进一步阐明这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The angiogram-negative subarachnoid hemorrhage (SAH) literature includes patients with perimesencephalic hemorrhage, which is recognized to have a much better outcome than aneurysmal SAH. OBJECTIVE: To evaluate the clinical outcomes of Nonperimesencephalic Angiogram-Negative SAH (NPAN-SAH). METHODS: A prospective, spontaneous SAH database of 1311 patients that accrued between April 2006 and December 2014 was screened. All patients with NPAN-SAH and 2 consecutive negative cerebral angiograms were included. RESULTS: We identified 191 (11%) from a total of 1311 patients with spontaneous SAH. Amongst angiogram-negative patients, 83 (4.9%) were adjudicated to have NPAN-SAH. Patient characteristics were similar across the groups, except NPAN-SAH patients were more likely to be men and had higher rates of diabetes. In a multivariable logistic regression model, NPAN-SAH patients were less likely to develop vasospasm, after adjusting for Fisher grade, sex, and diabetes (odds ratio [OR]: 0.197, 95% confidence interval [CI; 0.07-0.55], P = .002). In another adjusted model accounting for Hunt and Hess clinical grade, NPAN-SAH patients were also less likely to develop vasospasm (OR: 0.2, 95% CI [0.07-0.57], P = .002). We found no statistical significance between 2 groups for rebleed, developing hydrocephalus, seizures, or delayed cerebral ischemia. NPAN-SAH patients were equally associated with poor functional outcome (modified Rankin scale ≥3; OR: 1.16, 95% CI [0.615-2.20], P = .6420), and death (OR: 1.22, 95% CI [0.362-4.132], P = .7455) compared to aneurysmal SAH. CONCLUSION: Although the risk of vasospasm may be lower, patients with NPAN-SAH are equally associated with delayed cerebral ischemia, poor outcome, and death as compared to patients with aneurysmal SAH. Furthers studies may be necessary to further clarify these findings.
引用
- Al-Mufti F, Merkler AE, Boehme AK, et al. Functional Outcomes and Delayed Cerebral Ischemia Following Nonperimesencephalic Angiogram-Negative Subarachnoid Hemorrhage Similar to Aneurysmal Subarachnoid Hemorrhage. Neurosurgery. 2018. PMID: 28575305. doi:10.1093/neuros/nyx188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。